Clinical dosage and effectiveness study of ShanStar® Cranberry supplement for prevention and treatment against women's urinary tract infections: a double blind, randomised, placebo-controlled clinical study

ShanStar Biotech, Inc.0 个研究点目标入组 60 人开始时间: 2011年3月18日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Age between the age of 18-50
•2. Female gender
•3. Healthy individual with 3 or more episodes of urinary tract infections per year
•4. Able to complete the research study

•1. Terminal diesease or dementia
•2. Abstain from any cranberry, health food fruit extracts, anti-oxidants, vitamins, minerals and antibiotics for 2 weeks prior to participation in the study
•3. Pregnancy
•4. Urine catherisation within previous 2 weeks of study
•5. Participants with history of diabetes, cardiovascular disease, symptoms of pyelonephritis and stones in the urinary tract
•6. Sexually transmitted disease
•7. Pyuria or bacteriuria on urinalysis or positive urine culture ( will be treated and wait 2 weeks to be eligible)

发起方

ShanStar Biotech, Inc.